-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Rhythm Pharmaceuticals, Raises Price Target to $167

Benzinga·12/12/2025 13:14:52
语音播报
Citizens analyst Jonathan Wolleben maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Market Outperform and raises the price target from $141 to $167.